Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel N Wolfe

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Tropical Medicine and Hygiene|May 21, 2014
Current strategic thinking for the development of a trivalent alphavirus vaccine for human useDaniel N Wolfe, D Gray Heppner, Shea N Gardner, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
Frontiers in Cellular and Infection Microbiology|August 25, 2012
Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit modelRoy E Barnewall, Jason E Comer, Brian D Miller, et al.
Plos One|December 24, 2014
Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolatesJean F Challacombe, Chris J Stubben, Christopher P Klimko, et al.
Vaccine|November 1, 2020
Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or olderDaniel N Wolfe, Eric M Espeland, Yonghong Gao, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
Viruses|October 27, 2022
Natural History of Marburg Virus Infection to Support Medical Countermeasure DevelopmentJason E Comer, Trevor Brasel, Shane Massey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)-Supported Phase 2b Study DesignsDaniel N Wolfe, Elizabeth Arangies, Gloria L David, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Tropical Medicine and Hygiene|May 21, 2014
Current strategic thinking for the development of a trivalent alphavirus vaccine for human useDaniel N Wolfe, D Gray Heppner, Shea N Gardner, et al.
Vaccines|September 28, 2021
Selection of Filovirus Isolates for Vaccine Development ProgramsDaniel N Wolfe, Carol L Sabourin, Michael J Merchlinsky, et al.
Frontiers in Cellular and Infection Microbiology|August 25, 2012
Achieving consistent multiple daily low-dose Bacillus anthracis spore inhalation exposures in the rabbit modelRoy E Barnewall, Jason E Comer, Brian D Miller, et al.
Plos One|December 24, 2014
Interrogation of the Burkholderia pseudomallei genome to address differential virulence among isolatesJean F Challacombe, Chris J Stubben, Christopher P Klimko, et al.
Vaccine|November 1, 2020
Evaluation of BioThrax® and AV7909 anthrax vaccines in adults 66 years of age or olderDaniel N Wolfe, Eric M Espeland, Yonghong Gao, et al.
Vaccines|August 26, 2022
The Evolution of Medical Countermeasures for Ebola Virus Disease: Lessons Learned and Next StepsIan Crozier, Kyla A Britson, Daniel N Wolfe, et al.
Viruses|October 27, 2022
Natural History of Marburg Virus Infection to Support Medical Countermeasure DevelopmentJason E Comer, Trevor Brasel, Shane Massey, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 28, 2024
Development of Next-Generation COVID-19 Vaccines: Biomedical Advanced Research and Development Authority (BARDA-)-Supported Phase 2b Study DesignsDaniel N Wolfe, Elizabeth Arangies, Gloria L David, et al.
Vaccines|June 24, 2022
Natural History of <i>Sudan ebolavirus</i> to Support Medical Countermeasure DevelopmentCaroline Carbonnelle, Marie Moroso, Delphine Pannetier, et al.
NPJ Vaccines|April 12, 2023
Mucosal vaccines for SARS-CoV-2: scientific gaps and opportunities-workshop reportJane M Knisely, Lucas E Buyon, Rebecca Mandt, et al.
Pageof 4